Skip to content
HowShorted

Monopar Therapeutics short interest in 2021

In 2021, Monopar Therapeutics's disclosed short interest ran from 0.21% of shares outstanding on 15 Jan 2021 to 0.22% on 31 Dec 2021, a change of +0.01 percentage points. The year's high was 0.77% on 15 Sep 2021 and its low 0.17% on 26 Feb 2021, averaging 0.43% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.90 days on 30 Jul 2021. Full history: Monopar Therapeutics.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Monopar Therapeutics in 2021

2021 in figures

Start of year
0.21% (15 Jan 2021)
End of year
0.22% (31 Dec 2021)
Change
+0.01 pp
High
0.77% (15 Sep 2021)
Low
0.17% (26 Feb 2021)
Average
0.43%
Highest days to cover
7.90 (30 Jul 2021)
SEC filings marked
8

Every report in 2021

Monopar Therapeutics short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20210.21%1.00
29 Jan 20210.21%1.00
12 Feb 20210.24%1.00
26 Feb 20210.17%1.00
15 Mar 20210.17%1.00
31 Mar 20210.21%1.0010-K filed, results (8-K)
15 Apr 20210.31%1.00
30 Apr 20210.47%1.59
14 May 20210.55%3.8110-Q filed, results (8-K)
28 May 20210.54%3.04
15 Jun 20210.54%1.54
30 Jun 20210.55%1.62
15 Jul 20210.55%4.29
30 Jul 20210.50%7.90
13 Aug 20210.50%1.0010-Q filed, results (8-K)
31 Aug 20210.42%2.72
15 Sep 20210.77%1.00
30 Sep 20210.64%3.34
15 Oct 20210.62%4.24
29 Oct 20210.69%3.44
15 Nov 20210.63%1.5410-Q filed, results (8-K)
30 Nov 20210.40%2.31
15 Dec 20210.30%2.39
31 Dec 20210.22%1.00

See also: Monopar Therapeutics's full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.